These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33732206)

  • 21. Diffusion tensor imaging reveals changes in non-fat infiltrated muscles in late onset Pompe disease.
    Rehmann R; Froeling M; Rohm M; Forsting J; Kley RA; Schmidt-Wilcke T; Karabul N; Meyer-Frießem CH; Vollert J; Tegenthoff M; Vorgerd M; Schlaffke L
    Muscle Nerve; 2020 Oct; 62(4):541-549. PubMed ID: 32654203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study.
    Figueroa-Bonaparte S; Llauger J; Segovia S; Belmonte I; Pedrosa I; Montiel E; Montesinos P; Sánchez-González J; Alonso-Jiménez A; Gallardo E; Illa I; ; Díaz-Manera J
    Sci Rep; 2018 Jul; 8(1):10898. PubMed ID: 30022036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is early detection of late-onset Pompe disease a pneumologist's affair? A lesson from an Italian screening study.
    Confalonieri M; Vitacca M; Scala R; Polverino M; Sabato E; Crescimanno G; Ceriana P; Antonaglia C; Siciliano G; Ring N; Zacchigna S; Salton F; Vianello A;
    Orphanet J Rare Dis; 2019 Mar; 14(1):62. PubMed ID: 30832705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic tools in late onset Pompe disease (LOPD).
    Musumeci O; Toscano A
    Ann Transl Med; 2019 Jul; 7(13):286. PubMed ID: 31392198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inspiratory Muscle Training in Late-Onset Pompe Disease: The Effects on Pulmonary Function Tests, Quality of Life, and Sleep Quality.
    Aslan GK; Huseyinsinoglu BE; Oflazer P; Gurses N; Kiyan E
    Lung; 2016 Aug; 194(4):555-61. PubMed ID: 27106274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle MRI in McArdle Disease: A European Multicenter Observational Study.
    Løkken N; Revsbech KL; Jacobsen LN; Martinuzzi A; Martin MÁ; Díaz-Manera J; Dominguez-Gonzalez C; Brondani G; Musumeci O; Granata F; Stefan C; Merino-Sanchez C; Peralta CN; Khawajazada T; Alonso-Pérez J; Toscano A; Vissing J
    Neurology; 2022 Oct; 99(15):e1664-e1675. PubMed ID: 35853747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI changes in diaphragmatic motion and curvature in Pompe disease over time.
    Harlaar L; Ciet P; van Tulder G; van Kooten HA; van der Beek NAME; Brusse E; de Bruijne M; Tiddens HAWM; van der Ploeg AT; van Doorn PA
    Eur Radiol; 2022 Dec; 32(12):8681-8691. PubMed ID: 35829785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment.
    Montagnese F; Barca E; Musumeci O; Mondello S; Migliorato A; Ciranni A; Rodolico C; De Filippi P; Danesino C; Toscano A
    J Neurol; 2015; 262(4):968-78. PubMed ID: 25673129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung MRI and impairment of diaphragmatic function in Pompe disease.
    Wens SC; Ciet P; Perez-Rovira A; Logie K; Salamon E; Wielopolski P; de Bruijne M; Kruijshaar ME; Tiddens HA; van Doorn PA; van der Ploeg AT
    BMC Pulm Med; 2015 May; 15():54. PubMed ID: 25943437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory failure and sleep-disordered breathing in late-onset Pompe disease: a narrative review.
    Shah NM; Sharma L; Ganeshamoorthy S; Kaltsakas G
    J Thorac Dis; 2020 Oct; 12(Suppl 2):S235-S247. PubMed ID: 33214927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression from respiratory dysfunction to failure in late-onset Pompe disease.
    Berger KI; Chan Y; Rom WN; Oppenheimer BW; Goldring RM
    Neuromuscul Disord; 2016 Aug; 26(8):481-9. PubMed ID: 27297666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study.
    van der Ploeg A; Carlier PG; Carlier RY; Kissel JT; Schoser B; Wenninger S; Pestronk A; Barohn RJ; Dimachkie MM; Goker-Alpan O; Mozaffar T; Pena LD; Simmons Z; Straub V; Guglieri M; Young P; Boentert M; Baudin PY; Wens S; Shafi R; Bjartmar C; Thurberg BL
    Mol Genet Metab; 2016 Sep; 119(1-2):115-23. PubMed ID: 27473031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of Diaphragm Mechanics in Pompe Disease Using Dynamic 3D MRI.
    Mogalle K; Perez-Rovira A; Ciet P; Wens SC; van Doorn PA; Tiddens HA; van der Ploeg AT; de Bruijne M
    PLoS One; 2016; 11(7):e0158912. PubMed ID: 27391236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease.
    Byrne BJ; Geberhiwot T; Barshop BA; Barohn R; Hughes D; Bratkovic D; Desnuelle C; Laforet P; Mengel E; Roberts M; Haroldsen P; Reilley K; Jayaram K; Yang K; Walsh L;
    Orphanet J Rare Dis; 2017 Aug; 12(1):144. PubMed ID: 28838325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The emerging phenotype of late-onset Pompe disease: A systematic literature review.
    Chan J; Desai AK; Kazi ZB; Corey K; Austin S; Hobson-Webb LD; Case LE; Jones HN; Kishnani PS
    Mol Genet Metab; 2017 Mar; 120(3):163-172. PubMed ID: 28185884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative whole-body magnetic resonance imaging in children with Pompe disease: Clinical tools to evaluate severity of muscle disease.
    Fernandes SA; Khan AA; Boggs T; Bowling M; Austin S; Stefanescu M; Case L; Kishnani PS
    JIMD Rep; 2021 Jan; 57(1):94-101. PubMed ID: 33473345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bent spine syndrome as the initial symptom of late-onset Pompe disease.
    Taisne N; Desnuelle C; Juntas Morales R; Ferrer Monasterio X; Sacconi S; Duval F; Sole G; Flipo RM; Lacour A; Vermersch P; Cardon T
    Muscle Nerve; 2017 Jul; 56(1):167-170. PubMed ID: 27862019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional variation of thigh muscle fat infiltration in patients with neuromuscular diseases compared to healthy controls.
    Greve T; Burian E; Zoffl A; Feuerriegel G; Schlaeger S; Dieckmeyer M; Sollmann N; Klupp E; Weidlich D; Inhuber S; Löffler M; Montagnese F; Deschauer M; Schoser B; Bublitz S; Zimmer C; Karampinos DC; Kirschke JS; Baum T
    Quant Imaging Med Surg; 2021 Jun; 11(6):2610-2621. PubMed ID: 34079727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central drive and ventilatory failure in late-onset Pompe disease: At the gates of a new phenotype.
    De Vito EL; Arce SC; Monteiro SG; Vaca Ruiz GA
    Neuromuscul Disord; 2019 Jun; 29(6):444-447. PubMed ID: 31130377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Yield of Chilaiditi's Sign in Advanced-Phase Late-Onset Pompe Disease.
    Takahashi J; Mori-Yoshimura M; Ariga H; Sato N; Nishino I; Takahashi Y
    J Neuromuscul Dis; 2022; 9(5):619-627. PubMed ID: 35964201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.